Drug intelligence / Profile preview

oleocanthal

Development stage
Preclinical
Lead developer
University of Puglia
Modality
Small Molecules
Administration
Oral (as Part Of Olive Oil Or In Purified Dietary Supplement Form)
01

Overview

Oleocanthal is a naturally occurring phenolic compound, specifically a phenylethanoid and a monophenolic secoiridoid, found exclusively in extra virgin olive oil[1][2][3][4][9]. Its chemical structure is 2-(p-hydroxyphenyl)ethyl ester of (3S)-4-formyl-3-(2-oxoethyl)hex-4-enoic acid, and it is a tyrosol ester related to oleuropein[8][9]. Oleocanthal is responsible for the characteristic pungency (“throat burn”) in high-quality olive oils[4][5][7]. The principal mechanism of action is its non-selective inhibition of cyclooxygenase-1 and cyclooxygenase-2 (COX-1, COX-2), similar to ibuprofen but with greater potency on a molar basis[1][3][5][7][9]. It also disrupts multiple signaling pathways in cancer and inflammatory processes, including inhibition of mTOR, STAT3, Akt, MAPK, and B-Raf, and suppresses the inflammasome cascade[1]. Oleocanthal has shown anti-cancer, anti-inflammatory, antioxidant, neuroprotective, antimicrobial, anti-fibrotic, and potential anti-Alzheimer’s effects in vitro and in vivo[1][3][4][5][7][9]. Its health impacts are being actively researched as a nutraceutical and for possible use as a supportive agent in cancer therapy and chronic inflammatory diseases[1][4][5][6][7].

Other names
2-(4-hydroxyphenyl)ethyl (3S,4E)-4-formyl-3-(2-oxoethyl)hex-4-enoate(-)-oleocanthal
02

Targets

mTOR (Mammalian target of rapamycin kinase)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)STAT3 (Signal Transducer and Activator of Transcription 3)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on oleocanthal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oleocanthal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call